AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MICROSAIC SYSTEMS PLC

Director's Dealing Jun 12, 2019

7786_dirs_2019-06-12_0ad4b6c5-39d2-419c-a0fc-56c6acd1b66c.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0018C

Microsaic Systems plc

12 June 2019

12 June 2019

Microsaic Systems plc

("Microsaic", "Microsaic Systems" or the "Company")

Award of options

Microsaic Systems plc (AIM: MSYS), the developer of point-of-need mass spectrometry ("MS") instruments, announces that on 12 June 2019, the Company has approved the award of options ("New Options") to executive directors over 5,000,000 ordinary shares of 0.25 pence each in the Company ("Ordinary Shares"), representing approximately 1.10% of the issued share capital of the Company. 

Options have been granted to directors as detailed below:

Director Position Number of New Options Awarded Exercise Price of New Options Total Options Held
Glenn Tracey Chief Executive Officer 2,500,000 1.55 pence 4,800,000
Bevan Metcalf Finance Director 2,500,000 1.55 pence 4,620,000

The New Options awarded to the executive directors were awarded under Microsaic's Enterprise Management Incentive (EMI) Scheme. The New Options have an exercise price of 1.55 pence per Ordinary Share, being the middle market closing price on 11 June 2019. These options are subject to performance criteria as well as not being ordinarily exercisable prior to the third anniversary of the date of award. The performance criteria are:

1.    The Company to achieve break-even in a financial year (50% of New Options vest)

2.    Launch by the Company of a bio-pharma OEM product (50% of New Options vest)

Following the award of the New Options, the total number of options outstanding under share incentive scheme arrangements is 18,744,000 representing 4.11% of the Company's issued share capital.

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide additional detail.

Enquiries:
Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD
+44 (0)1483 751 577
N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson (Corporate Finance)

Tom Salvesen (Corporate Broking)
+44 (0)20 7496 3000
IFC Advisory Ltd (Financial PR)

Graham Herring

Heather Armstrong

Florence Chandler
+44 (0)20 3934 6630

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

Microsaic's products retain the functionality of larger conventional MS systems, but are deployable for use at the point of need, easier to use by non-specialists, consume less energy and have lower running costs. For more information, please go to www.microsaic.com.  

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Glenn Tracey

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Share options over ordinary shares of 0.25p each

GB00B547ZY09

b)

Nature of the transaction

Award of share options over ordinary shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
1.55 pence 2,500,000

d)

Aggregated information

- Aggregated volume

- Price

Not applicable

e)

Date of the transaction

12 June 2019

f)

Place of the transaction

Off market

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bevan Metcalf

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Share options over ordinary shares of 0.25p each

GB00B547ZY09

b)

Nature of the transaction

Award of share options over ordinary shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
1.55 pence 2,500,000

d)

Aggregated information

- Aggregated volume

- Price

Not applicable

e)

Date of the transaction

12 June 2019

f)

Place of the transaction

Off market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHSFIFEEFUSEDM

Talk to a Data Expert

Have a question? We'll get back to you promptly.